During the past decade, Rocky Mountain Lions Eye Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Lions Eye Institute" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Lions Eye Institute" are "Glaucoma" (5 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Brain Metastases" (1 trials), "Carcinoma, Non Small Cell Lung" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Rocky Mountain Lions Eye Institute" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Lions Eye Institute" are "Drug" (14 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-00299804" (2 trials), "PF-02341066" (2 trials), "Placebo" (2 trials), "0.01% RO7058584" (1 trials) and "0.1% RO7058584" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Lions Eye Institute" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rocky Mountain Lions Eye Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Rocky Mountain Lions Eye Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Lions Eye Institute, 6 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".